The NLRP3 inflammasome complex is considered a possible therapeutic target for preventing various cognitive impairments due to its response to microbial infections and environmental stimuli [36], and it can activate caspase-1 and promote the maturation of IL-1β and IL-18 [37]. The gene discussed is IL1B; the disease is Cognitive impairment.